MA50533A - Imipridones pour gliomes - Google Patents
Imipridones pour gliomesInfo
- Publication number
- MA50533A MA50533A MA050533A MA50533A MA50533A MA 50533 A MA50533 A MA 50533A MA 050533 A MA050533 A MA 050533A MA 50533 A MA50533 A MA 50533A MA 50533 A MA50533 A MA 50533A
- Authority
- MA
- Morocco
- Prior art keywords
- imipridones
- gliomas
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762581478P | 2017-11-03 | 2017-11-03 | |
US15/947,840 US10172862B2 (en) | 2017-01-30 | 2018-04-08 | Imipridones for gliomas |
Publications (1)
Publication Number | Publication Date |
---|---|
MA50533A true MA50533A (fr) | 2020-09-09 |
Family
ID=63038820
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA050533A MA50533A (fr) | 2017-11-03 | 2018-11-05 | Imipridones pour gliomes |
Country Status (14)
Country | Link |
---|---|
US (4) | US10172862B2 (fr) |
EP (1) | EP3703681A4 (fr) |
JP (2) | JP7319989B2 (fr) |
KR (1) | KR20200117979A (fr) |
CN (2) | CN111818919A (fr) |
AU (1) | AU2018360752A1 (fr) |
BR (1) | BR112020008791A2 (fr) |
CA (1) | CA3080815A1 (fr) |
EA (1) | EA202090928A1 (fr) |
IL (1) | IL274194A (fr) |
MA (1) | MA50533A (fr) |
MX (1) | MX2020004375A (fr) |
SG (1) | SG11202003952YA (fr) |
WO (1) | WO2019090222A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2018009227A (es) | 2016-01-29 | 2018-11-09 | Oncoceutics Inc | Modulacion del receptor acoplado a proteina g (gpcr) por imipridones. |
US10172862B2 (en) | 2017-01-30 | 2019-01-08 | Oncoceutics, Inc. | Imipridones for gliomas |
WO2020172485A1 (fr) * | 2019-02-22 | 2020-08-27 | Board Of Regents, The University Of Texas System | Procédés d'utilisation d'imipridones |
JP2023536524A (ja) | 2020-08-06 | 2023-08-25 | エトヴェシュ ロラーンド トゥドマニュジェテム | 新規イミプリドン誘導体の合成とその抗癌活性の評価 |
CN113248465B (zh) * | 2021-06-16 | 2021-10-29 | 中国农业科学院北京畜牧兽医研究所 | 一种鹰嘴豆芽素a的合成方法 |
CN114632088B (zh) * | 2022-05-16 | 2022-08-16 | 北京市神经外科研究所 | 阿糖胞苷化合物在制备治疗脊髓胶质瘤的药物中的用途 |
WO2024030645A1 (fr) * | 2022-08-05 | 2024-02-08 | Chimerix, Inc. | Compositions pharmaceutiques et leurs utilisations pour le traitement du gliome |
CN117731654B (zh) * | 2024-02-18 | 2024-05-07 | 首都医科大学附属北京天坛医院 | Jjh201601在初发性脑胶质瘤和复发性脑胶质瘤治疗中的新用途 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1638178A (en) * | 1924-11-04 | 1927-08-09 | Union Switch & Signal Co | Railway-traffic-controlling apparatus |
US4867973A (en) | 1984-08-31 | 1989-09-19 | Cytogen Corporation | Antibody-therapeutic agent conjugates |
WO2004082570A2 (fr) | 2003-03-17 | 2004-09-30 | Bayer Healthcare Ag | Diagnostics et traitements contre des maladies associees au recepteur d2 de la dopamine (drd2) |
EP1644536A4 (fr) | 2003-07-08 | 2008-07-23 | Univ California | Marqueur genetique de reponse a des antipsychotiques atypiques et a des antidepresseurs et leurs methodes d'utilisation |
US8088895B2 (en) | 2006-10-18 | 2012-01-03 | Chemocentryx, Inc. | Antibodies that bind CXCR7 epitopes |
CA2699912A1 (fr) * | 2007-09-19 | 2009-03-26 | Oncofluor, Inc. | Procede d'imagerie et de traitement d'organes et de tissus |
US20130102477A1 (en) * | 2010-06-23 | 2013-04-25 | Ryan D. Morin | Biomarkers for non-hodgkin lymphomas and uses thereof |
AU2012222812A1 (en) | 2011-02-28 | 2013-05-02 | Mcmaster University | Treatment of cancer with dopamine receptor antagonists |
SI2701708T1 (sl) | 2011-04-29 | 2020-07-31 | The Penn State Research Foundation | Induciranje malomolekulskega gena TRAIL z normalnimi in tumorskimi celicami kot terapija proti raku |
EP3572083A1 (fr) * | 2013-03-13 | 2019-11-27 | Oncoceutics, Inc. | 7-benzyl-10-(2-méthylbenzyle)-2,6,7,8,9,10-hexahydroimidazo[1,2-a]pyrido[4,3-d]pyrimidine-5(3h)-on à utiliser dans le traitement du cancer |
US9688679B2 (en) * | 2013-03-13 | 2017-06-27 | Oncoceutics, Inc. | 7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapy |
WO2015073072A1 (fr) | 2013-11-15 | 2015-05-21 | Oncoceutics, Inc. | 7-benzyl-4-(2-méthylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1h)-one |
US9376437B2 (en) * | 2013-03-13 | 2016-06-28 | Oncoceutics, Inc | 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, salts thereof and methods of using the same in combination therapy |
CN110669047A (zh) * | 2013-11-15 | 2020-01-10 | 昂克希尔迪克斯有限公司 | 用于治疗癌症的化合物、其组合物及应用方法 |
HUE049013T2 (hu) | 2014-03-31 | 2020-08-28 | Scripps Research Inst | Farmakofór trail indukcióra |
CN104860948B (zh) | 2015-05-15 | 2017-09-26 | 南京盖特医药技术有限公司 | 咪唑并嘧啶酮类化合物及其制备方法和应用 |
MX2018009227A (es) * | 2016-01-29 | 2018-11-09 | Oncoceutics Inc | Modulacion del receptor acoplado a proteina g (gpcr) por imipridones. |
US10172862B2 (en) | 2017-01-30 | 2019-01-08 | Oncoceutics, Inc. | Imipridones for gliomas |
-
2018
- 2018-04-08 US US15/947,840 patent/US10172862B2/en active Active
- 2018-11-05 EP EP18872950.3A patent/EP3703681A4/fr active Pending
- 2018-11-05 CN CN201880079207.9A patent/CN111818919A/zh active Pending
- 2018-11-05 CA CA3080815A patent/CA3080815A1/fr active Pending
- 2018-11-05 CN CN202310393221.9A patent/CN116173036A/zh active Pending
- 2018-11-05 SG SG11202003952YA patent/SG11202003952YA/en unknown
- 2018-11-05 JP JP2020544569A patent/JP7319989B2/ja active Active
- 2018-11-05 WO PCT/US2018/059209 patent/WO2019090222A1/fr unknown
- 2018-11-05 EA EA202090928A patent/EA202090928A1/ru unknown
- 2018-11-05 KR KR1020207015865A patent/KR20200117979A/ko active Search and Examination
- 2018-11-05 AU AU2018360752A patent/AU2018360752A1/en active Pending
- 2018-11-05 MA MA050533A patent/MA50533A/fr unknown
- 2018-11-05 MX MX2020004375A patent/MX2020004375A/es unknown
- 2018-11-05 BR BR112020008791-2A patent/BR112020008791A2/pt unknown
- 2018-11-29 US US16/204,964 patent/US10369154B2/en active Active
-
2019
- 2019-07-30 US US16/526,444 patent/US10946022B2/en active Active
-
2020
- 2020-04-23 IL IL274194A patent/IL274194A/en unknown
-
2021
- 2021-02-09 US US17/171,532 patent/US20210236499A1/en active Pending
-
2023
- 2023-07-21 JP JP2023118821A patent/JP2023139152A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
MX2020004375A (es) | 2020-11-11 |
CN111818919A (zh) | 2020-10-23 |
CA3080815A1 (fr) | 2019-05-09 |
CN116173036A (zh) | 2023-05-30 |
US20210236499A1 (en) | 2021-08-05 |
JP2021502417A (ja) | 2021-01-28 |
US20180221375A1 (en) | 2018-08-09 |
BR112020008791A2 (pt) | 2020-10-20 |
EA202090928A1 (ru) | 2020-08-14 |
AU2018360752A1 (en) | 2020-05-21 |
US20190183895A1 (en) | 2019-06-20 |
EP3703681A4 (fr) | 2021-08-11 |
US10369154B2 (en) | 2019-08-06 |
KR20200117979A (ko) | 2020-10-14 |
EP3703681A1 (fr) | 2020-09-09 |
US10172862B2 (en) | 2019-01-08 |
JP2023139152A (ja) | 2023-10-03 |
SG11202003952YA (en) | 2020-05-28 |
IL274194A (en) | 2020-06-30 |
JP7319989B2 (ja) | 2023-08-02 |
WO2019090222A1 (fr) | 2019-05-09 |
US10946022B2 (en) | 2021-03-16 |
US20200022982A1 (en) | 2020-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3731771T3 (da) | V462033dk00 | |
DE202018003363U8 (de) | Handgelenkssphygmomanometer | |
MA50533A (fr) | Imipridones pour gliomes | |
CL2018000524S1 (es) | Golilla | |
DK3351526T3 (da) | Diisopentylterephthalat | |
FR3036518B1 (fr) | Inversion pour contrainte tectonique | |
DK3387930T3 (da) | Stofanordning | |
DK3568655T3 (da) | Rekuperator | |
DK3571580T5 (da) | Load-logical-and-shift-guarded-instruktion | |
DK3612237T3 (da) | Genterapi | |
DK3568506T3 (da) | Offeranode | |
IT201700108243A1 (it) | Confezione | |
DK3576686T3 (da) | Brokbind | |
DK3676276T3 (da) | Spirothietannukleosider | |
DK3576718T3 (da) | Pastil | |
FI11704U1 (fi) | Liittopuujärjestely | |
DK3510051T3 (da) | Carboxylalkylchitosan | |
DK3714101T3 (da) | Sporskifte | |
DK3395159T3 (da) | Ballepresse | |
ES1205411Y (es) | Maleta-Gaveta | |
ES1198359Y (es) | Columbario | |
FI11529U1 (fi) | Ontelolaatan kannake | |
FR3046351B1 (fr) | Chariot- portoir pour brancard. | |
UA37486S (uk) | Опакування - етикетка для міні-круасанів | |
DK3645955T3 (da) | Buffertank |